Introduction
In 1994, HEAP Research BV was founded as a limited liability company according to Dutch law.
Main Objective:
To provide market access capability to manufacturers of pharmaceuticals and medical devices and technical consultation services to mainly the public and private sector to further the development of health care systems within the European Community, Eastern Europe and Developing Countries.
Senior Partners
- Frans van Andel, MSc, MPH, PhD
- Adam Barak, MCIM
- Nico Bruyniks, MD, MRCOG, MFFP
- Ron de Graaff, LLM
- Prof Smit Sibinga, MD, PhD, FRCP Edin, FRCP Path
- Jaap Wientjes
More Information
Services Offered
HEAP Research BV has developed an extensive set of market access and business advisory and project acquisition, development and management services for clients in the pharmaceutical and medical technology industries as well as healthcare policy and delivery organisations and investments in the health care sector .... -- read more --
Opportunities for potential HEAP Research BV clients
Market and investment opportunities for small and medium sized pharmaceutical and medical technology manufacturers and private and public health care providers in growth markets.... -- read more --
How we work
The steps that encompass the collaboration between HEAP Research BV and a new client, fee structure, consulting services, investment ownership.... -- read more --
Track record
Examples of past and present HEAP Research bv projects.... -- read more --